Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04337255 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet in Stroke Patients Patients

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion pushed from Jul 31, 2026 to May 31, 2027 Show 4 more changesShow less
    • Enrollment target: 250 to 266
    • Eligibility criteria expanded, about 25 words
    • Secondary endpoints: details revised at 1 of 2 entries
    • Publications: 4 to 11
  2. Primary completion date: Feb 28, 2027 to Jul 31, 2026
    • Study completion date: May 31, 2027 to Jul 31, 2026
    v10
  3. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Jan 31, 2027 to Feb 28, 2027
    • Site details revised
    v9
  4. Enrollment target: 500 to 250v8 Show 4 more changesShow less
    • Primary completion date: Jul 31, 2026 to Jan 31, 2027
    • Study completion date: Dec 31, 2026 to May 31, 2027
    • Secondary endpoints: details revised at 1 of 2 entries
    • Study description shortened, about 3 words
  5. Primary completion date: Jul 2026 to Jul 31, 2026
    • Study completion date: Dec 2026 to Dec 31, 2026
    v7
Show 5 earlier versionsHide 5 earlier versions
  1. Eligibility criteria expanded, about 2 wordsv6
  2. Eligibility criteria revisedv5
  3. Eligibility criteria shortened, about 2 wordsv4
  4. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Start date changed from estimate of Jul 2021 to Dec 14, 2021
    • Eligibility criteria revised
    • Study description revised
    • Site details revised
  5. Primary completion date: Dec 2025 to Jul 2026v2 Show 4 more changesShow less
    • Start date: Jun 2020 to Jul 2021
    • Study sites: 0 to 1
    • Study completion date: Dec 2025 to Dec 2026
    • Publications: 3 to 4
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To test the effects of a 2- to 3-year intervention of the MIND diet versus usual post-stroke care on cognitive decline, the characteristic feature of dementia, and on brain biomarkers of Alzheimer's Disease (AD) and vascular disease in a Phase Ill randomized controlled trial of 250 patients hospitalized for acute ischemic stroke, aged 55 years or older, and without dementia who are discharged home following hospitalization.
Trial Details
NCT Number NCT04337255
Lead Sponsor Rush University Medical Center
Collaborators: University of Chicago, Advocate Hospital System, National Institute on Aging (NIA)
Conditions
(from sponsor)		 Cognitive Decline, Dementia, Vascular, Alzheimer Disease, Dementia, Stroke
Related terms Alzheimer Disease, Cognitive Dysfunction, Dementia, Dementia, Vascular, Stroke
Enrollment 266 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov